Alpha Teknova (TKNO) Competitors $4.31 -0.09 (-2.05%) Closing price 04:00 PM EasternExtended Trading$4.31 0.00 (0.00%) As of 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TKNO vs. NTLA, AMPH, WVE, AUPH, ARDX, ELVN, VERV, NAGE, DYN, and CDTXShould you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include Intellia Therapeutics (NTLA), Amphastar Pharmaceuticals (AMPH), WAVE Life Sciences (WVE), Aurinia Pharmaceuticals (AUPH), Ardelyx (ARDX), Enliven Therapeutics (ELVN), Verve Therapeutics (VERV), Niagen Bioscience (NAGE), Dyne Therapeutics (DYN), and Cidara Therapeutics (CDTX). These companies are all part of the "pharmaceutical products" industry. Alpha Teknova vs. Its Competitors Intellia Therapeutics Amphastar Pharmaceuticals WAVE Life Sciences Aurinia Pharmaceuticals Ardelyx Enliven Therapeutics Verve Therapeutics Niagen Bioscience Dyne Therapeutics Cidara Therapeutics Intellia Therapeutics (NASDAQ:NTLA) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership. Do insiders & institutionals have more ownership in NTLA or TKNO? 88.8% of Intellia Therapeutics shares are held by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are held by institutional investors. 3.1% of Intellia Therapeutics shares are held by insiders. Comparatively, 12.5% of Alpha Teknova shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger earnings and valuation, NTLA or TKNO? Alpha Teknova has lower revenue, but higher earnings than Intellia Therapeutics. Alpha Teknova is trading at a lower price-to-earnings ratio than Intellia Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntellia Therapeutics$57.88M21.40-$519.02M-$5.23-2.29Alpha Teknova$37.74M6.10-$26.75M-$0.48-8.98 Which has more volatility & risk, NTLA or TKNO? Intellia Therapeutics has a beta of 2.21, meaning that its share price is 121% more volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500. Do analysts prefer NTLA or TKNO? Intellia Therapeutics presently has a consensus price target of $33.37, indicating a potential upside of 179.00%. Alpha Teknova has a consensus price target of $12.00, indicating a potential upside of 178.42%. Given Intellia Therapeutics' higher possible upside, equities analysts clearly believe Intellia Therapeutics is more favorable than Alpha Teknova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intellia Therapeutics 1 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.65Alpha Teknova 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is NTLA or TKNO more profitable? Alpha Teknova has a net margin of -60.90% compared to Intellia Therapeutics' net margin of -1,154.10%. Alpha Teknova's return on equity of -28.48% beat Intellia Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Intellia Therapeutics-1,154.10% -56.06% -44.25% Alpha Teknova -60.90%-28.48%-19.73% Does the media prefer NTLA or TKNO? In the previous week, Intellia Therapeutics had 4 more articles in the media than Alpha Teknova. MarketBeat recorded 5 mentions for Intellia Therapeutics and 1 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 1.01 beat Intellia Therapeutics' score of 0.48 indicating that Alpha Teknova is being referred to more favorably in the news media. Company Overall Sentiment Intellia Therapeutics Neutral Alpha Teknova Positive SummaryIntellia Therapeutics beats Alpha Teknova on 9 of the 17 factors compared between the two stocks. Get Alpha Teknova News Delivered to You Automatically Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TKNO vs. The Competition Export to ExcelMetricAlpha TeknovaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$235.14M$2.91B$5.52B$9.32BDividend YieldN/A2.46%4.25%4.05%P/E Ratio-8.9820.3628.1519.68Price / Sales6.10304.13438.33100.29Price / CashN/A42.3835.5357.53Price / Book2.787.768.235.67Net Income-$26.75M-$55.11M$3.23B$257.51M7 Day Performance-18.37%0.95%-0.01%0.52%1 Month Performance-21.35%8.44%5.61%8.84%1 Year Performance219.26%-2.38%26.52%14.18% Alpha Teknova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TKNOAlpha Teknova2.0269 of 5 stars$4.31-2.0%$12.00+178.4%+243.8%$235.14M$37.74M-8.98240Positive NewsNTLAIntellia Therapeutics4.3855 of 5 stars$10.25-4.6%$33.37+225.5%-55.9%$1.11B$57.88M-1.96600AMPHAmphastar Pharmaceuticals4.2922 of 5 stars$22.86-1.5%$32.33+41.4%-45.4%$1.09B$731.97M8.282,028WVEWAVE Life Sciences4.4933 of 5 stars$7.06+1.6%$20.50+190.4%+28.7%$1.08B$108.30M-8.40240News CoverageAnalyst ForecastGap UpAUPHAurinia Pharmaceuticals3.1534 of 5 stars$7.47-1.6%$11.50+53.9%+58.6%$1.03B$235.13M26.68300Positive NewsARDXArdelyx4.0715 of 5 stars$4.35+1.9%$10.89+150.3%-24.4%$1.02B$333.61M-19.7790Analyst RevisionELVNEnliven Therapeutics2.7947 of 5 stars$19.59-5.5%$41.20+110.3%-13.7%$1.02BN/A-10.2050VERVVerve Therapeutics3.0169 of 5 stars$11.16-1.1%$14.57+30.6%+53.9%$1.01B$59.61M-5.29110NAGENiagen Bioscience0.8684 of 5 stars$12.44-2.1%$19.50+56.8%N/A$1.00B$99.60M73.18120DYNDyne Therapeutics3.8609 of 5 stars$8.18-6.6%$41.13+402.8%-80.9%$995.72MN/A-2.28100News CoverageAnalyst ForecastInsider TradeGap UpHigh Trading VolumeCDTXCidara Therapeutics3.6591 of 5 stars$48.30-1.0%$57.14+18.3%+311.9%$983.59M$1.27M-1.6490Positive NewsHigh Trading Volume Related Companies and Tools Related Companies NTLA Competitors AMPH Competitors WVE Competitors AUPH Competitors ARDX Competitors ELVN Competitors VERV Competitors NAGE Competitors DYN Competitors CDTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TKNO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredTrump has to finance $21 trillion. Here’s His Move…Trump needs $21 trillion to fund his agenda — and insiders believe he’s quietly preparing a major shift in the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Teknova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Teknova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TKNO Stock Alerts